User profiles for Sally Hodges

Sally Hodges

University of Kentucky, Walden University
Verified email at uky.edu
Cited by 3927

A randomized prospective multicenter trial of pancreaticoduodenectomy with and without routine intraperitoneal drainage

…, S Goldin, K Brown, S Mohammed, SE Hodges… - Annals of …, 2014 - journals.lww.com
Objective: To test by randomized prospective multicenter trial the hypothesis that
pancreaticoduodenectomy (PD) without the use of intraperitoneal drainage does not increase the …

[PDF][PDF] Ampullary cancers harbor ELF3 tumor suppressor gene mutations and exhibit frequent WNT dysregulation

…, H Wang, D Aust, KA Oien, RH Hruban, SE Hodges… - Cell reports, 2016 - cell.com
The ampulla of Vater is a complex cellular environment from which adenocarcinomas arise
to form a group of histopathologically heterogenous tumors. To evaluate the molecular …

A novel epigenetic CREB‐miR‐373 axis mediates ZIP4‐induced pancreatic cancer growth

…, JP Hagan, H Wang, X Yu, SE Hodges… - EMBO molecular …, 2013 - embopress.org
Changes in the intracellular levels of the essential micronutrient zinc have been implicated
in multiple diseases including pancreatic cancer; however, the molecular mechanism is …

Pancreatic resection without routine intraperitoneal drainage

WE Fisher, SE Hodges, EJ Silberfein, A Artinyan… - Hpb, 2011 - Wiley Online Library
Background: Most surgeons routinely place intraperitoneal drains at the time of pancreatic
resection but this practice has recently been challenged. Objective: Evaluate the outcome …

A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer

…, D Li, U Bharadwaj, M Li, C Chen, SE Hodges… - Clinical Cancer …, 2013 - AACR
Purpose: The majority of pancreatic cancers overexpress mesothelin (MSLN), which
contributes to enhanced proliferation, invasion, and migration. However, the MSLN regulatory …

[HTML][HTML] Engineered T cells for pancreatic cancer treatment

UL Katari, JM Keirnan, AC Worth, SE Hodges, AM Leen… - Hpb, 2011 - Elsevier
Objective Conventional chemotherapy and radiotherapy produce marginal survival benefits
in pancreatic cancer, underscoring the need for novel therapies. The aim of this study is to …

Assessment of the learning curve for pancreaticoduodenectomy

WE Fisher, SE Hodges, MF Wu, SG Hilsenbeck… - The American journal of …, 2012 - Elsevier
BACKGROUND: Experience with the Whipple procedure has been associated with improved
outcomes, but the learning curve for this complex procedure is not well defined. METHODS…

Treatment of bacteriobilia decreases wound infection rates after pancreaticoduodenectomy

S Mohammed, C Evans, G VanBuren, SE Hodges… - Hpb, 2014 - Wiley Online Library
Background Although mortality following pancreaticoduodenectomy is decreasing,
postoperative morbidity remains high. It was hypothesized that culture‐directed treatment of …

[HTML][HTML] Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells

…, PK Jonsson, JZ Lin, F Su, LR Bollu, SE Hodges… - PloS one, 2014 - journals.plos.org
Pancreatic ductal adenocarcinoma (PDAC) is difficult to detect early and is often resistant to
standard chemotherapeutic options, contributing to extremely poor disease outcomes. …

Intra-abdominal fat predicts survival in pancreatic cancer

CJ Balentine, J Enriquez, W Fisher, S Hodges… - Journal of …, 2010 - Elsevier
Background Body mass index (BMI) has proven unreliable in predicting survival following
pancreaticoduodenectomy for cancer. While measures of intra-abdominal fat correlate with …